Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Beta-Alanine and Increased Carnosine Level

Research synthesisModerate evidenceMixed effect size3 studies · 3 beneficial · 0 neutral · 0 harmful

Across 3 studies, all reported beneficial effects on increased carnosine levels with mixed effect sizes (small to large). The most commonly studied dose was 3.2 g/day, and effects were observed in clinical (COPD) and athletic (combat sports) populations. The median study duration was 84 days (12 weeks), suggesting effects typically require several weeks of supplementation.

  • Studied populations: patients with COPD, combat athletes

Caveats: Available evidence is overwhelmingly positive, but the evidence base is small (only 3 studies) — conclusions should be considered preliminary. Clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). Additionally, effect sizes varied widely across studies (small to large), and the dose was only specified in one study (3.2 g/day).

Generated Jul 12, 2026
Doses used in studies
  • g/day: 3.2 (median 3.2, IQR 3.23.2) 1 study
Time to effect
Median: 2.8 months · IQR 2.8 months2.8 months · Range 2.8 months2.8 months — Reported in 1 of 3 studies
Safety in these studies
3 of 3 papers
Back to top